Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 159–159 | Cite as

Iguratimod

Decreased WBC count: 2 case reports
Case report
  • 1 Downloads

Reference

  1. Gao H, et al. Efficacy and safety of iguratimod in patients with primary Sjogren syndrome: A follow-up study. Annals of the Rheumatic Diseases 78 (Suppl. 2): 1696 abstr. AB0465, Jun 2019. Available from: URL: http://doi.org/10.1136/annrheumdis-2019-eular.7472 [abstract] - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations